Page results
-
Autogenic Training (AT) is a technique offered by the Psychological Therapy Services Team at the Royal London Hospital for Integrated Medicine, which receives referrals for chronic physical health problems.
-
This information is for patients who are having radiotherapy to the pelvis.
-
This page explains the type of care we offer in the Supportive Care Unit at the University College Hospital Macmillan Cancer Centre.
-
Information about sickle cell disorder and pregnancy for UCLH patients.
-
This page aims to help you, your family or carers to plan ahead, and talk about decisions about your care or treatment that may need to be made in the future.
-
The flow cytometry laboratory provides a Haematological Malignancy diagnostic service which includes chronic and acute leukaemias and lymphomas.
-
Diet and nutrition advice for people experiencing weight loss, weight gain, appetite changes, difficulty eating, or other digestive problems which have happened as a result of their treatment or condition. Advice is also available for people who are confused about what diet or nutrition advice to follow.
-
Advice for University College London Hospital patients who have experienced hair loss.
-
Spinal tumours can cause pressure on the spinal cord and/or nerves and depending on where the tumour is in your spine, different areas of your body can be affected.
-
The London Sarcoma Service is one of the largest sarcoma services in Europe with an international reputation for providing the highest quality of care to patients with sarcoma.
File results
-
FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0514 - Viscosupplementation injections/ spend
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer